Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ARSJ |
| Upstream (Parents) |
|---|
| (<<) ANKRD27 → ARSJ |
| (<<) ARAF → ARSJ |
| (<<) ATF2 → ARSJ |
| (<<) CDR2 → ARSJ |
| (<<) CRTC1 → ARSJ |
| (<<) CYP1A2 → ARSJ |
| (<<) CYP2U1 → ARSJ |
| (<<) DUSP10 → ARSJ |
| (<<) LGALS3 → ARSJ |
| (<<) LRP5 → ARSJ |
| (<<) OSBPL8 → ARSJ |
| (<<) PDK1 → ARSJ |
| (<<) PLOD2 → ARSJ |
| (<<) PRKCD → ARSJ |
| (<<) PTPRE → ARSJ |
| (<<) SESN1 → ARSJ |
| (<<) STAM2 → ARSJ |
| Downstream (Children) |
|---|
| ARSJ → ACTC1 (>>) |
| ARSJ → CLCF1 (>>) |
| ARSJ → GLS (>>) |
| ARSJ → KLK3 (>>) |
| ARSJ → PHLDA1 (>>) |
| ARSJ → RHOF (>>) |
